Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2314 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Teva launches generic ADHD drug in US

Teva’s generic Adderall XR capsules are indicated for the treatment of attention deficit hyperactivity disorder (ADHD). In August 2006, Teva’s subsidiary Barr Pharmaceuticals entered into a licensing agreement

LDR wins FDA clearance for ROI-A ALIF device

Previously cleared in April 2008 as a partial vertebral body replacement, the ROI-A system incorporates the innovative VerteBRIDGE screwless plating technology. According to LDR, the ROI-A anterior lumbar

IntraNexus signs distribution agreement with Mediware

The agreement enables IntraNexus to re-market Mediware’s Ascend pharmacy-management system as an integrated component of the company’s Sapphire health information system. Sapphire is a comprehensive, web-based technology platform

Amicas completes acquisition of Emageon

Amicas’s acquisition of Emageon is expected to create a leading healthcare IT vendor, with more than 1,000 customers, that offers one of the most comprehensive image and information

MonoSol Rx wins new US patent

The patent relates to the delivery of an active ingredient, such as drugs or vitamins, contained in a thin film that is attached or placed inside of a